BMS-906024: Clinical Trials

4 trials of BMS-906024, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed. 4 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 14Completed 4

Follow BMS-906024: new trials by email Literature Review of BMS-906024 trials Research Report on BMS-906024

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
AL101 Before Surgery for the Treatment of Notch Activated Adenoid Cystic Cancer
AL101, Therapeutic Conventional Surgery - Adenoid Cystic Carcinoma, Metastatic Adenoid Cystic Carcinoma
Phase 1CompletedM.D. Anderson Cancer Center132021-09-302026-06-24
Study to Evaluate Safety & Tolerability of BMS-906024 in Combination With Chemotherapy & to Define DLTs & MTD of BMS-906024 in Combination With One of the Following Chemotherapy Regimens; Weekly Paclitaxel, 5FU+Irinotecan or Carboplatin+Paclitaxel in Subjects With Advanced / Metastatic Solid Tumors
Paclitaxel, 5-Fluorouracil (5FU), Carboplatin - Cancer
Phase 1CompletedBristol-Myers Squibb1412012-10-122020-01-28
Study to Evaluate the Safety and Tolerability of Weekly Intravenous (IV) Doses of BMS-906024 in Subjects With Acute T-cell Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma
BMS-906024, Dexamethasone - Lymphoblastic Leukemia, Acute T-cell, Precursor T-Cell Lymphoblastic Lymphoma
Phase 1CompletedBristol-Myers Squibb312011-09-282019-07-30
Study to Evaluate the Safety and Tolerability of IV Doses of BMS-906024 in Subjects With Advanced or Metastatic Solid Tumors
BMS-906024 - Cancer
Phase 1CompletedBristol-Myers Squibb942011-03-032020-01-27

Conditions studied

Neoplasms (2)  ·  Carcinoma, Adenoid Cystic (1)  ·  Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (1)

Sponsors

Bristol-Myers Squibb (3)  ·  M.D. Anderson Cancer Center (1)

Countries

United States (4)  ·  Canada (2)  ·  Australia (1)  ·  Belgium (1)  ·  France (1)  ·  Germany (1)

Top investigators

Renata Ferrarotto (1)

Results publications

PMID 34590610